Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Derosa

Showing results (51-60 of 109) with videos related to

Pageof 11
Sort By:
NPJ Precision Oncology|July 16, 2024
Antibiotics are associated with worse outcomes in lung cancer patients treated with chemotherapy and immunotherapyArielle Elkrief, Eder Orlando Méndez-Salazar, Jade Maillou, et al.
Aging|September 13, 2021
Circulating acetylated polyamines correlate with Covid-19 severity in cancer patientsMélanie Bourgin, Lisa Derosa, Carolina Alves Costa Silva, et al.
Oncology|February 17, 2017
Outcome of Patients with Renal Cell Carcinoma and Multiple Glandular Metastases Treated with Targeted AgentsPaolo Grassi, Ludovic Doucet, Palma Giglione, et al.
Oncoimmunology|September 16, 2020
Trial watch : the gut microbiota as a tool to boost the clinical efficacy of anticancer immunotherapyRomain Daillère, Lisa Derosa, Mélodie Bonvalet, et al.
Radiation Oncology (London, England)|January 23, 2016
[(18)F]Choline PET/CT and stereotactic body radiotherapy on treatment decision making of oligometastatic prostate cancer patients: preliminary resultsFrancesco Pasqualetti, Marco Panichi, Aldo Sainato, et al.
BMJ Open|January 12, 2026
Telehealth-delivered exercise and nutrition intervention to improve outcomes in patients with early stage non-small cell lung cancer: protocol for the multicentre STARLighT phase II (neoadjuvant) and phase III (adjuvant) trialAlice Avancini, Diana Giannarelli, Stefano Ugel, et al.
Oncoimmunology|January 12, 2023
RBD- specific Th1 responses are associated with vaccine-induced protection against SARS-CoV-2 infection in patients with hematological malignanciesCamille Bigenwald, Yacine Haddad, Cassandra Thelemaque, et al.
Clinical Genitourinary Cancer|January 1, 2020
On-target Toxicities Predictive of Survival in Metastatic Renal Cell Carcinoma (mRCC) Treated With Sunitinib: A Multicenter Retrospective StudyElena Bolzacchini, Graziella Pinotti, Lorenza Bertù, et al.
Plos One|April 12, 2016
Clinical Impact of Pancreatic Metastases from Renal Cell Carcinoma: A Multicenter Retrospective AnalysisPaolo Grassi, Ludovic Doucet, Palma Giglione, et al.
Targeted Oncology|January 7, 2015
Prognostic significance of host immune status in patients with late relapsing renal cell carcinoma treated with targeted therapyMatteo Santoni, Sebastiano Buti, Alessandro Conti, et al.
Pageof 11

Showing results (51-60 of 109) with videos related to

Sort By:
Pageof 11
NPJ Precision Oncology|July 16, 2024
Antibiotics are associated with worse outcomes in lung cancer patients treated with chemotherapy and immunotherapyArielle Elkrief, Eder Orlando Méndez-Salazar, Jade Maillou, et al.
Aging|September 13, 2021
Circulating acetylated polyamines correlate with Covid-19 severity in cancer patientsMélanie Bourgin, Lisa Derosa, Carolina Alves Costa Silva, et al.
Oncology|February 17, 2017
Outcome of Patients with Renal Cell Carcinoma and Multiple Glandular Metastases Treated with Targeted AgentsPaolo Grassi, Ludovic Doucet, Palma Giglione, et al.
Oncoimmunology|September 16, 2020
Trial watch : the gut microbiota as a tool to boost the clinical efficacy of anticancer immunotherapyRomain Daillère, Lisa Derosa, Mélodie Bonvalet, et al.
Radiation Oncology (London, England)|January 23, 2016
[(18)F]Choline PET/CT and stereotactic body radiotherapy on treatment decision making of oligometastatic prostate cancer patients: preliminary resultsFrancesco Pasqualetti, Marco Panichi, Aldo Sainato, et al.
BMJ Open|January 12, 2026
Telehealth-delivered exercise and nutrition intervention to improve outcomes in patients with early stage non-small cell lung cancer: protocol for the multicentre STARLighT phase II (neoadjuvant) and phase III (adjuvant) trialAlice Avancini, Diana Giannarelli, Stefano Ugel, et al.
Oncoimmunology|January 12, 2023
RBD- specific Th1 responses are associated with vaccine-induced protection against SARS-CoV-2 infection in patients with hematological malignanciesCamille Bigenwald, Yacine Haddad, Cassandra Thelemaque, et al.
Clinical Genitourinary Cancer|January 1, 2020
On-target Toxicities Predictive of Survival in Metastatic Renal Cell Carcinoma (mRCC) Treated With Sunitinib: A Multicenter Retrospective StudyElena Bolzacchini, Graziella Pinotti, Lorenza Bertù, et al.
Plos One|April 12, 2016
Clinical Impact of Pancreatic Metastases from Renal Cell Carcinoma: A Multicenter Retrospective AnalysisPaolo Grassi, Ludovic Doucet, Palma Giglione, et al.
Targeted Oncology|January 7, 2015
Prognostic significance of host immune status in patients with late relapsing renal cell carcinoma treated with targeted therapyMatteo Santoni, Sebastiano Buti, Alessandro Conti, et al.
Pageof 11